AIG
PHAT icon

American International Group’s Phathom Pharmaceuticals PHAT Stock Holding History

American International Group’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,802
Closed -$168K – 1975
2024
Q1 		$168K Sell
15,802
-136
-0.9% -$1.16K ﹤0.01% 2244
2023
Q4 		$146K Buy
15,938
+529
+3% +$4.56K ﹤0.01% 2348
2023
Q3 		$160K Buy
15,409
+3,563
+30% +$48.9K ﹤0.01% 2246
2023
Q2 		$170K Buy
11,846
+6
+0.1% +$69 ﹤0.01% 2271
2023
Q1 		$84.5K Buy
11,840
+236
+2% +$2.07K ﹤0.01% 2534
2022
Q4 		$130K Buy
11,604
+671
+6% +$6.92K ﹤0.01% 2383
2022
Q3 		$121K Buy
10,933
+155
+1% +$1.48K ﹤0.01% 2449
2022
Q2 		$91K Buy
10,778
+723
+7% +$7.43K ﹤0.01% 2654
2022
Q1 		$137K Sell
10,055
-708
-7% -$11.4K ﹤0.01% 2458
2021
Q4 		$212K Sell
10,763
-322
-3% -$7.58K ﹤0.01% 2334
2021
Q3 		$356K Sell
11,085
-263
-2% -$8.74K ﹤0.01% 2071
2021
Q2 		$384 Buy
11,348
+4,601
+68% +$165K ﹤0.01% 2093
2021
Q1 		$253 Buy
6,747
+502
+8% +$21K ﹤0.01% 2241
2020
Q4 		$207 Sell
6,245
-179
-3% -$7.25K ﹤0.01% 2271
2020
Q3 		$236K Sell
6,424
-146
-2% -$5.06K ﹤0.01% 2039
2020
Q2 		$216K Buy
6,570
+200
+3% +$7.68K ﹤0.01% 2076
2020
Q1 		$164K Sell
6,370
-368
-5% -$12.3K ﹤0.01% 2013
2019
Q4 		$210K Buy
+6,738
New +$169K ﹤0.01% 2192

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

American International Group's PHAT Position: Q2 2024 in Review

American International Group sold out of Phathom Pharmaceuticals (PHAT) in Q2 2024, closing a stake of 15,802 shares — an estimated $168K sold.

American International Group first reported a position in PHAT in Q4 2019 and held it in 18 quarters. The position peaked at $356K in Q3 2021. 114 funds tracked by Wall St. Rank hold PHAT as of Q2 2024.

  • American International Group reported no remaining Phathom Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 15,802 Phathom Pharmaceuticals shares in Q2 2024, an estimated $168K.
  • American International Group first reported a position in Phathom Pharmaceuticals in Q4 2019 and held it in 18 quarters.
  • American International Group's Phathom Pharmaceuticals position peaked at $356K in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.